Novavax reported on March 11 that its COVID-19 vaccine is 96% efficacious in reducing mild, moderate or severe disease. The Maryland-based company joins the handful of manufacturers that have reported encouraging data on a COVID-19 vaccine; three, Pfizer-BioNTech, Moderna and Johnson & Johnson’s Janssen Pharmaceuticals, have already received emergency use authorization for their shots from … Read more
Europe was one of the first regions to be hit hard by COVID-19 last spring. In mid-May 2020, the World Health Organization declared it the “epicenter” of the pandemic, with more reported cases and deaths than the rest of the world combined. From there, in many ways, the European experience of COVID-19 mirrored the U.S. … Read more
A final analysis of the Novavax vaccine candidate in two trials in the United Kingdom and South Africa found it was strongly effective in preventing illness, although less so against the variant first detected in South Africa. The vaccine completely protected against all cases of severe disease. View original article Contributor: Carolyn Y. Johnson
At Day 50, supply and shots are picking up thanks to White House efforts — and adjustments set in motion by the Trump administration. View original article Contributor: Dan Diamond
Millions of people have received the vaccine without safety problems, and there is no evidence of any causal link between the vaccine and blood clots. View original article Contributor: Rebecca Robbins and Thomas Erdbrink
Enough vaccine from the drug maker AstraZeneca for about millions of doses sits in U.S. manufacturing plants, awaiting regulatory approval as the world goes begging. View original article Contributor: Noah Weiland and Rebecca Robbins
Some events are relocating to the water, some are being postponed, and others are now taking place in cars. View original article Contributor: Campbell Robertson
Utiliza coronavirus inactivados para entrenar el sistema inmunitario. View original article Contributor: Jonathan Corum and Carl Zimmer
Utiliza coronavirus inactivos para entrenar al sistema inmunitario. View original article Contributor: Jonathan Corum and Carl Zimmer
Lead screenings for children plummeted last spring, and stay-at-home orders may have increased household exposure to the toxic metal. View original article Contributor: Emily Anthes